Example: tourism industry
Recombinant protein vaccines produced in insect cells
Measles Measles virus (genus Morbillivirus, family Paramyxoviridae) H and F proteins H, F, and N viral proteins Rubella Rubella virus (= togavirus of the genus Rubivirus) E1 HPV Human papilloma virus (>100 subtypes) L1 structural protein Japanese Encephalitis JapaneseEncephalitis (JE) virus (Flaviviridae) Glycoprotein E
Tags:
Information
Domain:
Source:
Link to this page:
Documents from same domain
INVESTING IN HEALTH FOR ECONOMIC …
www.who.int2 INVESTING IN HEALTH FOR ECONOMIC DEVELOPMENT Report by the Mexican Commission on Macroeconomics and health 3 The …
WHO GOOD PRACTICES FOR PHARMACEUTICAL …
www.who.intworking document qas/09.297/rev.2 page 2 schedule for the proposed adoption process of document qas/09.297/rev.2: who good practices for pharmaceutical microbiology laboratories
NORMES ET STANDARDS EN INFRASTRUCTURES …
www.who.intnormes et standards en infrastructures et equipements du centre de sante et de promotion sociale, du centre medical avec antenne chirurgicale et du …
Heterotrophic Plate Count Measurement in …
www.who.intWorld Health Organization Sustainable Development and Healthy Environments Heterotrophic Plate Count Measurement in Drinking Water Safety Management
Annex 3 WHO good manufacturing practices for ...
www.who.int96 Introduction The fi rst WHO draft text on good manufacturing practices (GMP) was prepared in 1967 by a group of consultants at the request of the Twentieth
Annex 5 WHO good distribution practices for …
www.who.int236 1. Introduction Distribution is an important activity in the integrated supply-chain management of pharmaceutical products. Various people and entities are
Annex 2 WHO good practices for pharmaceutical …
www.who.int71 Introduction and scope of document Pharmaceutical microbiology laboratories may be involved in: — sterility testing; — detection, isolation, enumeration and identifi cation of microorganisms
LABORATORY BIOSAFETY MANUAL - WHO
www.who.intinterim guidelines WHO/CDS/CSR/LYO/2003.4 LABORATORY BIOSAFETY MANUAL SECOND EDITION (REVISED) WORLD HEALTH ORGANIZATION Geneva 2003
Mycobacteriology Laboratory Manual - WHO
www.who.intMycobacteriology Laboratory Manual ii Edita Pimkina, Infectious Diseases and Tuberculosis Hospital Affi liate of Public institution …
Laboratory Guidelines for enumerating CD4 T …
www.who.intSEA-HLM-392 Distribution: Limited Laboratory Guidelines for enumerating CD4 T Lymphocytes in the context of HIV/AIDS Regional Office for South-East Asia
Related documents
Vaccine Information Statement: HPV (Human Papillomavirus ...
www.immunize.orgHPV (human papillomavirus) vaccine can prevent infection with some types of human papillomavirus. HPV infections can cause certain types of cancers, including: cervical, vaginal, and vulvar cancers in women penile cancer in men anal cancers in both men and women cancers of tonsils, base of tongue, and back of
Adeno-Associated Virus and AAV Vectors
www.uvm.eduupon co-infection or super infection with a helper virus - such as adenovirus (Ad), Herpes Simplex Virus (HSV) or Human Papilloma Virus (HPV). This is characterized by DNA replication, viral gene expression and virion production. When AAV infects human cells in the absence of a helper virus, its gene expression program is
Papiloma escamoso oral: reporte de un caso clínico
www.medigraphic.comPalabras clave: Papiloma escamoso oral, virus del papiloma humano, lesión oral. ABSTRACT Oral squamous papilloma is an exophytic mass resulting from a benign proliferation of stratifi ed squamous epithelium induced by human papillomavirus (types 6 and 11). This condition is characterized by
VACCINES AND DIALYSIS - National Kidney Foundation
www.kidney.org(MMR), varicella (chickenpox), meningococcus, and human papilloma virus (HPV). There is also a vaccine to protect against hepatitis A virus (HAV), which attacks the liver. It can be very serious and can spread to make other people sick. Hepatitis A is spread through close personal contact and by eating contaminated food or water.
VACCINATION CONSENT FORM - Pharmasave
pharmasave.comHuman Papilloma Virus . Trade Name Dose 2: 2 months Lot No Expiry Date 9 - 26 yrs: 0.5 mL IM 1 2 3 Dose 3: 6 months Date: Date & time of vaccination Site: Left arm Right arm Herpes Zoster (shingles) Trade Name Lot No Expiry Date 50 yrs + IM SC 1 2 Primary dose only Dose 2: 2-6 months Date:
Chapter 5 Infection Control: Principles and Practices
cpb-us-e1.wpmucdn.com© Copyright 2012 Milady, a part of Cengage Learning. All Rights Reserved. May not be scanned, copied, or duplicated, or posted to a publicly accessible website, in ...